Related Experiment Video
Updated: Jul 13, 2026

Nerve-sparing Mid-urethral Obstruction (NeMO) in Female Small Rodents
Published on: April 25, 2017
[Oral pharmacological treatments for sphincteric dysfunction in neurourology]
F Giuliano1, P Denys, E Chartier-Kastler
1Service de médecine physique et de réadaptation, Raymond Poincaré, Université Versailles Saint-Quentin en Yvelines, Garches, France. giuliano@cyber-sante.org
Abstract:
Sphincter dysfunction is an almost constant pathological process in neurourology. No oral pharmacological treatment is available to treat stress urinary incontinence secondary to sphincter incompetence or to relieve urethral hypertonia usually induced by detrusor-sphincter dyssynergia. The few treatments that induce sphincter relaxation are not sufficient to justify a routine therapeutic indication.
Related Concept Videos
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Direct-Acting Cholinergic Agonists: Pharmacological Actions
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
Skeletal Muscle Relaxants: Therapeutic Uses
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Antihypertensive Drugs: Vasodilators

